asthma
Conditions
Interventions
treat:QiXian decoction
control:8% QiXian decoction
Sponsors
Shanghai university of traditional chinese medicine affilated putuo hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients agree and paper signed; 2. Patients aged from 18 to 75; 3. Asthma diagnosis is clear; 4. All patients were in regular treatment with combinations of ICS plus/or LABA; 5. Enrolled patients had a Forced Expiratory Volume in one second (FEV1) 60% to 80% of predicted normal; 6. The patients are capable of filling diary.
Exclusion criteria
Exclusion criteria: 1. patients younger than 18 and older than 75; 2. no asthma patients; 3. long-term treatment with drugs which influence the judgement of effect and security; 4. participating other clinical trial, or specific immunologic treatment(monoclonal antibodies) in 6 months; 5. allergy to test drug or components; 6. smoking; 7. addiction to drugs or alcohol; 8. severe patient; 9. malignant tumor in 5 years; 10. accompanied with heart or other systemic diseases; 11. ALT or AST high than 2 times of normal level; 12. Creatinine more than 159µmol/L in male or > 141µmol/L in women; 13. pregnant or lactation women; 14. investigators do not approve.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ACT score; | — |
Countries
China
Contacts
Public ContactXiongbiao Wang
Shanghai university of traditional chinese medicine affilated putuo hospital
Outcome results
None listed